Sign In
Buy CTIC
$9.09
+0 (+0%)
At Close: Sep 22, 2023
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10:58pm, Thursday, 28'th Jan 2021
SEATTLE, Jan. 28, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees with a gr
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
07:04am, Friday, 01'st Jan 2021
Innovation paid off big for investors.
CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15
07:00am, Tuesday, 08'th Dec 2020
SEATTLE, Dec. 8, 2020 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at The JMP Securities Hematology Summit at 3:00 p.m. EST. The
CTI BioPharma: Accelerated Approval Pathway Looks Attractive
02:33pm, Sunday, 06'th Dec 2020
CTIC recently received FDA's accelerated approval go-ahead for pacritinib in MF patients with severe thrombocytopenia. This considerably reduces the risks associated with the company.
SEATTLE, Dec. 6, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation supporting the Company's pacritinib development program in the prevention of acute graft v
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q3 2020 Results - Earnings Call Transcript
10:37pm, Tuesday, 10'th Nov 2020
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q3 2020 Results - Earnings Call Transcript
CTI BioPharma Announces Oral Presentation at the 62nd American Society of Hematology Meeting
11:41am, Wednesday, 04'th Nov 2020
SEATTLE, Nov. 4, 2020 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced an oral presentation supporting the Company's pacritinib development program in graft versus host disease (GVHD
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
08:09am, Monday, 26'th Oct 2020
Timothy P. Lynch's Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies. The fund takes a lo
CTI BioPharma: A Nano Cap With Interesting Prospects
01:19am, Saturday, 05'th Sep 2020
The prospect of an accelerated approval has lifted the share price of CTI BioPharma. However, the company has faced serious issues due to the clinical hold by the FDA in the past.
EU-UK deadlock on trade talks goes on with time running out
10:22am, Friday, 21'st Aug 2020
The European Union and Britain ended another negotiating round on their future trade ties after Brexit in a deep deadlock on Friday
EU refuses to monitor Venezuelan election, urges delay
03:29pm, Tuesday, 11'th Aug 2020
The European Union says it won’t send observers to monitor Venezuela’s upcoming congressional election, citing a lack of fair conditions for a vote that could erase the opposition’s last major d
Belarusian challenger flees to Lithuania amid protests
10:23am, Tuesday, 11'th Aug 2020
The top opposition candidate in Belarus' presidential vote who refused to concede her defeat has fled the country amid a massive police crackdown on protests, Lithuania's foreign minister said Tuesday
Wall Street Analysts Are Bullish on Top Healthcare Picks - Markets
03:53pm, Friday, 07'th Aug 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CTI BioPharma
CTI BioPharma Reports Second Quarter 2020 Financial Results
08:05pm, Thursday, 06'th Aug 2020
CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the second quarter and six months ended June 30, 2020.
Air France-KLM: Don't Expect Full Recovery In The Next Couple Of Years (OTCMKTS:AFLYY)
08:28am, Wednesday, 05'th Aug 2020
In Q2, Air France–KLM lost €2.6 billion. The distrust between the Dutch and French governments, the upcoming second wave of the pandemic in Europe, and the long recovery are making the airline uni
